BrainsWay Announces Data from Feasibility Study of Deep Transcranial Magnetic Stimulation System in the treatment of Adults with ADHD
10 févr. 2020 09h00 HE
|
BrainsWay Ltd.
Results demonstrate increased activity in attention-related brain networks treated with BrainsWay’s H6-coil, which correlate with observed improvement in ADHD symptoms PATTERSON, N.J., Feb. 10, 2020...
BrainsWay Appoints Avner Lushi to Join Board of Directors
10 févr. 2020 07h00 HE
|
BrainsWay Ltd.
PATTERSON, N.J., Feb. 10, 2020 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay”), a commercial stage medical device company focused on the development and sale of...
BrainsWay Reports Results of Interim Analysis of H7 Deep Transcranial Magnetic Stimulation Study in Post-Traumatic Stress Disorder
06 févr. 2020 07h00 HE
|
BrainsWay Ltd.
PATTERSON, N.J., Feb. 06, 2020 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay”) today announced interim results from a multicenter randomized controlled double-blind...
BrainsWay Announces Successful Results in Pivotal Multicenter Study Evaluating Deep Transcranial Magnetic Stimulation System as an Aid in Smoking Cessation
02 déc. 2019 07h00 HE
|
BrainsWay Ltd.
Primary and secondary endpoint achieved with statistical significance Company intends to meet with FDA shortly to discuss planned regulatory submission and potential clearance pathway JERUSALEM,...
BrainsWay Reports Third Quarter 2019 Financial Results and Operational Highlights
25 nov. 2019 07h00 HE
|
BrainsWay Ltd.
JERUSALEM, Israel and HACKENSACK, N.J., Nov. 25, 2019 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced non-invasive...
BrainsWay Appoints Medical Technology Industry Leader Christopher R. von Jako, Ph.D., as President and Chief Executive Officer
25 nov. 2019 06h05 HE
|
BrainsWay Ltd.
JERUSALEM and HACKENSACK, N.J., Nov. 25, 2019 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) and its subsidiary BrainsWay USA, Inc., a global leader in the advanced non-invasive...
Der neue Stimulator für tiefe transkranielle Magnetstimulation von BrainsWay feiert Deutschlandpremiere auf dem Kongress der Deutschen Gesellschaft für Psychiatrie, Psychotherapie und Psychosomatik 2019
25 nov. 2019 03h00 HE
|
Brainsway Ltd.
JERUSALEM, Nov. 25, 2019 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ: BWAY, TASE: BWAY), ein weltweit führendes Unternehmen in der fortschrittlichen nicht-invasiven Behandlung von Hirnerkrankungen,...
BrainsWay‘s New Stimulator for Deep Transcranial Magnetic Stimulation Makes German Debut at the 2019 German Association for Psychiatry, Psychotherapy and Psychosomatics Congress
25 nov. 2019 03h00 HE
|
BrainsWay Ltd.
JERUSALEM, Nov. 25, 2019 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ: BWAY, TASE: BWAY), a global leader in the advanced non-invasive treatment of brain disorders, announced today that it will be...
BrainsWay to Report Third Quarter 2019 Financial Results on November 25, 2019
14 nov. 2019 16h01 HE
|
BrainsWay Ltd.
JERUSALEM and HACKENSACK, N.J., Nov. 14, 2019 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced non-invasive treatment of...
A Stepping Stone Hosts Open House to Introduce Newly Offered FDA-Cleared Helmet to Treat Major Depressive Disorder (MDD)
29 oct. 2019 11h00 HE
|
BrainsWay Ltd.
GREENWOOD VILLAGE, Colo., Oct. 29, 2019 (GLOBE NEWSWIRE) -- A Stepping Stone, a full-service outpatient mental health clinic with advanced treatments for mental health disorders, announced today...